drug package inserts การใช้

• All legally approved indications are listed on the drug package insert or " label ".
• In 2008, the United States Food and Drug Administration ( FDA ) requested that all quinolone / fluoroquinolone drugs package inserts include a Black Boxed Warning concerning the risk of spontaneous tendon ruptures, which would have included flumequine.
• The drug package insert contains a black-box warning _ required by the U . S . government for drugs with potentially serious side effects _ and says it should not be used by patients with kidney disease or on drug treatment for heart failure.